U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Shockwave Therapy for Pain Associated with Upper Extremity Orthopedic Disorders: A Review of the Clinical and Cost-Effectiveness

Shockwave Therapy for Pain Associated with Upper Extremity Orthopedic Disorders: A Review of the Clinical and Cost-Effectiveness

Rapid Response Report: Summary with Critical Appraisal

Orthopedic disorders encompass a variety of conditions including rotator cuff tendinopathy (shoulder disorder), epicondylitis (elbow disorder), patellar tendinosis (knee disorder) and plantar fasciitis (foot disorder) and are often associated with pain. Disorders such as these may be associated with decreased productivity or disability that may last several months resulting in a financial burden to society. Conventional therapies used in general practice to manage pain include rest, ice, nonsteroidal anti-inflammatory drugs, physical therapy, and subacromial corticosteroid injections. , Patients unresponsive to such therapies may need to undergo surgical procedures. Shockwave therapy (SWT) may be an alternative to surgical procedures which can be expensive and associated with risk. Other therapeutic modalities include laser therapy, radiation therapy, and transcutaneous electric nerve stimulation (TENS).

SWT involves acoustic waves which carry energy to painful spots and musculoskeletal tissues with subacute, subchronic and chronic conditions. This energy assists in regeneration and repair of bones, tendons and other soft tissues. The exact mechanism of action is not clear. The interaction of shockwaves with tissue is thought to cause stimulation of tissue healing, breakdown of calcification, alteration of cell membrane permeability, and alteration of cell activity through cavitation. , Devices used for SWT vary in design, depending on the way shockwaves are generated and the level of energy that it can produce. Generally, the shockwaves are generated by electrohydraulic, electromagnetic or piezoelectric mechanisms. SWT includes focused shockwave therapy (FSWT) and radial shockwave therapy (RSWT). FSWT is based on shockwaves of single pressure pulses of a microsecond duration, which are focused on a specific target using ultrasound or radiography guidance. RSWT is a low- to medium- energy shockwave that is pneumatically generated through the acceleration of a projectile inside the hand-piece of the medical device and then transmitted radially from the tip of the applicator to the target area.

SWT has been used for over two decades for the treatment soft tissue and bone related musculoskeletal disorders. There is however some debate regarding the effectiveness of SWT compared to placebo or other treatment modalities.

The purpose of this report is to review the clinical effectiveness and cost-effectiveness of shockwave therapy for pain associated with upper extremity orthopedic disorders. A separate report will review the clinical effectiveness and cost-effectiveness of shockwave therapy for pain associated with lower extremity orthopedic disorders.

Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should be considered along with other types of information and health care considerations. The information included in this response is not intended to replace professional medical advice, nor should it be construed as a recommendation for or against the use of a particular health technology. Readers are also cautioned that a lack of good quality evidence does not necessarily mean a lack of effectiveness particularly in the case of new and emerging health technologies, for which little information can be found, but which may in future prove to be effective. While CADTH has taken care in the preparation of the report to ensure that its contents are accurate, complete and up to date, CADTH does not make any guarantee to that effect. CADTH is not liable for any loss or damages resulting from use of the information in the report.

Copyright © 2016 Canadian Agency for Drugs and Technologies in Health.

Copyright: This report contains CADTH copyright material and may contain material in which a third party owns copyright. This report may be used for the purposes of research or private study only. It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner.

Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK395736PMID: 27831675

Views

Other titles in this collection

Related information

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...